Kolon Biotech, Inc. announced that it will issue 147,000 common shares at an issue price of KRW 17,000 for gross proceeds of KRW 2,499,000,000 on October 18, 2022. The transaction included participation returning investor Kolon Life Science Inc. The transaction was approved board of directors of the company.